Abstract Objective To investigate the antigen clearance time, time to symptom disappearance, and the association between them using immunofluorescence assay for dynamic monitoring of influenza virus antigen in children with influenza. Methods A total of 1 063 children suspected of influenza who visited the Hunan People's Hospital from March to April, 2016 were enrolled. The influenza A/B virus antigen detection kit (immunofluorescence assay) was used for influenza virus antigen detection. The children with positive results were given oseltamivir as the antiviral therapy and were asked to re-examine influenza virus antigen at 5, 5-7, and 7 days after onset. Results Of all children suspected of influenza, 560 (52.68%) had an influenza virus infection. A total of 215 children with influenza virus infection were followed up. The clearance rate of influenza virus antigen was 9.8% (21 cases) within 5 days after onset. The cumulative clearance rate of influenza virus antigen was 32.1% (69 cases) within 5-7 days, and 98.1% (211 cases) within 7-10 days after onset. Among these children, 6 children (2.8%) achieved the improvement in clinical symptoms within 3 days after onset. The cumulative rate of symptom improvement was 84.7% (182 cases) within 3-5 days after onset, and 100% achieved the improvement after 5 days of onset. Conclusions The time to improvement in symptoms after treatment is earlier than antigen clearance time. Almost all of the children achieve influenza virus antigen clearance 7-10 days after onset. Therefore, it is relatively safe for children to go back to school within 7-10 days after onset when symptoms disappear.
Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States[J]. JAMA, 2004, 292(11):1333-1340.
[3]
Melchior TB, Perosa AH, Camargo CN, et al. Influenza virus prevalence in asymptomatic and symptomatic subjects during pandemic and postpandemic periods[J]. Am J Infect Control, 2015, 43(5):460-464.
[4]
Ikematsu H, Kawai N, Iwaki N, et al. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan[J]. J Infect Chemother, 2014, 20(2):77-80.
Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years:a 25-year prospective study[J]. J Infect Dis, 2002, 185(2):147-152.
[9]
Kondo H, Shobugawa Y, Hibino A, et al. Influenza virus shedding in laninamivir-treated children upon returning to school[J]. Tohoku J Exp Med, 2016, 238(2):113-121.
